Stockscreener 앱 받기
71.67
3.46%
-2.57
시간 외 거래:
71.61
-0.06
-0.08%
Bridgebio Pharma Inc 주식(BBIO)의 최신 뉴스
89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd - MarketBeat
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 40,000 Shares of Stock - MarketBeat
BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock By Investing.com - Investing.com Canada
Bridgebio Pharma Insider Sold Shares Worth $5,908,476, According to a Recent SEC Filing - marketscreener.com
BridgeBio Pharma (NASDAQ:BBIO) Hits New 12-Month HighTime to Buy? - MarketBeat
Price-Driven Insight from (BBIO) for Rule-Based Strategy - news.stocktradersdaily.com
BridgeBio Pharma, Inc. $BBIO Holdings Lifted by Bosun Asset Management LLC - MarketBeat
Tema Etfs LLC Sells 25,530 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Edgestream Partners L.P. Makes New $1.92 Million Investment in BridgeBio Pharma, Inc. $BBIO - MarketBeat
BridgeBio Pharma, Inc. $BBIO Position Cut by Affinity Asset Advisors LLC - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Norges Bank Purchases New Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Lymphatic Malformations Market Expected to Experience Major - openPR.com
Legal & General Group Plc Purchases 23,716 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Panagora Asset Management Inc. Boosts Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat
72,047 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by Capital Fund Management S.A. - MarketBeat
Rhumbline Advisers Grows Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
How BridgeBio Pharma Inc. stock valuations compare to rivalsMarket Activity Recap & Free Fast Gain Swing Trade Alerts - Newser
BridgeBio Pharma stock hits 52-week high at $72.36 By Investing.com - Investing.com South Africa
BridgeBio Pharma (NASDAQ:BBIO) Reaches New 52-Week HighWhat's Next? - MarketBeat
BridgeBio Pharma stock hits 52-week high at $72.36 - Investing.com
What valuation multiples suggest for BridgeBio Pharma Inc. stockJuly 2025 EndofMonth & Accurate Entry and Exit Point Alerts - Newser
Prudential Financial Inc. Has $5.07 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
What dividend safety score for BridgeBio Pharma Inc. stockJuly 2025 Reactions & High Yield Stock Recommendations - Newser
BridgeBio Pharma Surges 170% as New Clinical Partnerships Spark Valuation Debate - Yahoo Finance
Is BridgeBio Pharma Inc. (2CL) stock cheap by valuation metricsJuly 2025 Snapshot & Consistent Income Trade Recommendations - Newser
Can BridgeBio Pharma Inc. (2CL) stock ride next bull market cycleJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Should You Grab This ‘Strong Buy’ Growth Stock With 56% Upside? - Yahoo Finance
Swiss National Bank Has $10.99 Million Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
F m Investments LLC Decreases Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat
American Century Companies Inc. Buys 62,646 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Why BridgeBio Pharma Inc. stock could rally in 2025Quarterly Performance Summary & AI Powered Market Entry Strategies - BỘ NỘI VỤ
BridgeBio Pharma, Inc. $BBIO Shares Purchased by Cetera Investment Advisers - MarketBeat
Franklin Resources Inc. Acquires 482,149 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Breakout Move: Will BridgeBio Pharma Inc. stock maintain growth storyMarket Performance Recap & Daily Price Action Insights - BỘ NỘI VỤ
BridgeBio (BBIO) Q3 2025 Earnings Call Transcript - The Globe and Mail
(BBIO) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
BridgeBio Pharma’s Attruby Launch Drives Revenue Jump In Q3 - Finimize
BridgeBio to Participate in December Investor Conferences - The Manila Times
BridgeBio Pharma Insider Sold Shares Worth $1,722,224, According to a Recent SEC Filing - MarketScreener
BridgeBio Pharma CEO Kumar Neil sells $1.7m in shares By Investing.com - Investing.com Nigeria
BridgeBio Pharma CEO Kumar Neil sells $1.7m in shares - Investing.com
BridgeBio Pharma CEO Neil Kumar Sells Shares - TradingView
Biotech Stock Could Turn 4-Year Peak Into Records - Finviz
BridgeBio Pharma stock hits 52-week high at 69.69 USD By Investing.com - Investing.com Nigeria
BridgeBio Pharma stock hits 52-week high at 69.69 USD - Investing.com
BridgeBio Pharma: Set For New Commercial Launches After Trial Successes - Seeking Alpha
Creative Planning Boosts Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
BridgeBio Pharma (BBIO) Price Target Increased by 16.55% to 82.90 - MSN
Artisan Partners Limited Partnership Has $13.74 Million Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
BridgeBio Pharma Independent Director Wen-Chaun Lo Sells 62% Of Holding - simplywall.st
Ensign Peak Advisors Inc Sells 534,060 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Will BridgeBio Pharma Inc. stock split attract more investors2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com
Will BridgeBio Pharma Inc. (2CL) stock outperform value peersWall Street Watch & Low Drawdown Investment Ideas - newser.com
Will BridgeBio Pharma Inc. stock gain from lower inflationJuly 2025 Short Interest & Short-Term High Return Strategies - newser.com
BridgeBio Pharma (NASDAQ:BBIO) Director Sells $3,612,950.00 in Stock - MarketBeat
Why BridgeBio Pharma Inc. (2CL) stock stays resilientMarket Volume Report & Weekly High Momentum Picks - newser.com
1.50%
자본화:
|
볼륨(24시간):